The Evolving Landscape in Mantle Cell Lymphoma

home / peer-exchange / the-evolving-landscape-in-mantle-cell-lymphoma

EP. 1: Accurately Diagnosing Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 19th 2021

EP. 2: Treatment Approaches in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 19th 2021

EP. 3: Go-To Treatment Regimens in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 26th 2021

EP. 4: Lenalidomide and Bortezomib for Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

January 26th 2021

EP. 5: BTK Inhibitors for Relapsed Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 2nd 2021

EP. 6: Acalabrutinib and Zanubrutinib for Relapsed MCL

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 2nd 2021

EP. 7: Selecting a BTKi for Relapsed MCL Treatment

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 9th 2021

EP. 8: BTK Inhibitors for Relapsed MCL: Important Considerations

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 9th 2021

EP. 9: Venetoclax in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 16th 2021

EP. 10: CAR T-Cell Therapy for R/R Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 16th 2021

EP. 11: Emerging BTK Inhibitors in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 23rd 2021

EP. 12: MCL: Emerging BTKi-Combination Approaches

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

February 23rd 2021

EP. 13: Novel Therapies in the Pipeline in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

March 2nd 2021

EP. 14: MRD Assessment in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

March 2nd 2021

EP. 15: Next Steps in Mantle Cell Lymphoma

By John P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine
Krish Patel, MD, Swedish Medical Center

March 2nd 2021

Latest Conference Coverage

Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer

As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority

Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD

Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512